Cambronne Laboratories
Lulu A. Cambronne, Ph.D
Hon. B.Sc. University of Toronto, 2003
Ph.D. Harvard University, 2009
Lulu Cambronne, Ph.D. is currently a Research Assistant Professor in the Vollum Institute and Oregon Health & Science University. Dr. Cambronne has a longstanding interest in the molecular mechanisms that underlie physiology and disease. A theme throughout her work includes the development of new molecular tools to address previously unattainable questions. The current research focus of the Cambronne group is to understand how changes in free nicotinamide adenine dinucleotide (NAD+) levels contribute to the progression and onset of age-related diseases. Under her direction, a collaborative team composed of members from the Goodman and Cohen labs developed a genetically-encoded fluorescent biosensor to monitor subcellular free NAD+ regulation in cells.
​
Dr. Cambronne has been honored both at the pre-doctoral and post-doctoral levels with individual Kirschstein National Service Research Awards from the National Institutes of Health, Albert J Ryan and Samuel Lunenfeld Fellowships, and named the 2013 OHSU New Inventor of the year for her development and commercialization of the RISC-trap/miR-trap assay to empirically identify targets for specific microRNAs in cells.